Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06332092
Title FID-007 and Cetuximab in Treating Patients With Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
Acronym HNSCC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fulgent Pharma LLC.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Highlands Oncology - North Hills RECRUITING Fayetteville Arkansas 72703 United States Details
USC/Norris Comprehensive Cancer Center and Hospital RECRUITING Los Angeles California 90033 United States Details
Moffitt Cancer Center Magnolia Campus RECRUITING Tampa Florida 33612 United States Details
Fort Wayne Medical Oncology and Hematology RECRUITING Fort Wayne Indiana 46804 United States Details
Texas Oncology - Baylor Charles A. Sammons Cancer Center RECRUITING Dallas Texas 75246 United States Details
Texas Oncology - Northeast Texas Cancer & Research Institute RECRUITING Tyler Texas 75702 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field